Nishank Bhalla, Ph.D.
Chief Executive Officer
Nishank leads Advanced Virology as CEO, bringing deep molecular virology expertise to the company's scientific direction, product strategy, and execution. He focuses the team on customer value by connecting research needs with high-fidelity viral systems, assay-enabling reagents, and credible delivery plans that support serious laboratory work.
LinkedIn → William Klimstra, Ph.D.
Chief Science Officer
William is a senior virologist whose expertise anchors AV's credibility in viral systems, infectious-disease research, and translational applications. He advises on scientific direction, technical differentiation, and the research standards that make AV valuable to customers and collaborators.
LinkedIn → Whitney Lane, Ph.D.
Director of Laboratory Operations
Whitney leads the operating backbone of the lab, turning scientific priorities into coordinated workflows, documentation, and reproducible laboratory execution. Her work keeps the team aligned across production planning, SOP adherence, supplier coordination, and the day-to-day discipline required for dependable virology materials.
LinkedIn → Hailong Guo, Ph.D.
Senior Scientist
Hailong brings deep virology and immune-response research experience to Advanced Virology, with a focus on translating rigorous viral systems into repeatable lab and production workflows. He helps shape the scientific standards behind AV's engineered virus stocks, manufacturing readiness, and quality-forward product development.
LinkedIn → Sierra Downs, MBA
Operations & Compliance
Sierra supports the company's operating discipline across documentation, regulated workflows, partner coordination, and quality-minded execution. She helps translate the team's scientific and commercial priorities into practical processes for scaling a focused virology products business.
LinkedIn → Doug Butdorf
Strategy & Growth
Doug leads Advanced Virology's commercial strategy, capital formation, GTM systems, and partner development work. He brings company-building experience across pricing, operations, real estate, and early-stage growth to help AV turn scientific strength into durable market position.
LinkedIn →